期刊文献+

儿茶酚抑素对心梗大鼠心肌纤维化的影响

Effect of catechol endostatin on myocardial fibrosis in rats with myocardial infarction
下载PDF
导出
摘要 目的探讨儿茶酚抑素(CST)治疗对心梗(MI)大鼠心肌纤维化的影响。方法结扎SD大鼠冠状动脉前降支建立心肌梗死模型,将模型大鼠随机分为儿茶酚抑素组、心梗对照组,每组16只,另设假手术组16只。术后1 d开始,儿茶酚抑素组连续3周腹腔注射儿茶酚抑素2 nmol/(kg·d),心梗对照组和假手术组给予等量生理盐水腹腔注射。4周后,记录左室血流动力学改变;处死大鼠,留取心脏标本,Masson染色检测心肌纤维化;Western blot法检测梗死周边Ⅰ胶原蛋白表达。结果与心梗对照组比较,儿茶酚抑素组的心功能损害较轻(P<0.01),梗死百分比及胶原含量显著降低(P<0.05,P<0.01)。结论儿茶酚抑素能改善心脏功能,并能减轻心梗后非梗死区反应性胶原的过多沉积,预防心梗后心肌纤维化。 Objective To investigate the effect of catechol endostatin on myocardial fibrosis in rats with myocardial infarction(MI).Methods MI model of Sprague-Dawley(SD)rat was established by ligating the left anterior descending coronary artery.Rats were randomly divided into MI group(n = 16)and CST group(n = 16),and 16 rats were chosen as sham group.Rats in CST group were given CST 2 nmol/(kg·d)ip for 3 weeks at first day after operation,while an equal amount of 0.9% normal saline was applied to MI group and sham group.The left ventricular hemodynamics was measured.Myocardial interstitial fibrosis was observed by Masson staining,and the peripheral collagenⅠ was detected by western blot.Results Compared with MI group,cardiac function damage was milder in CST group(P〈0.01).Collagen content and infarct size decreased significantly(P〈0.05,P〈0.01).Conclusion CST can improve the cardiac function and reduce reactive myocardial fibrosis,thus preventing myocardial fibrosis.
出处 《实用药物与临床》 CAS 2016年第4期414-417,共4页 Practical Pharmacy and Clinical Remedies
基金 湖北省自然科学基金面上项目(2015CFB615) 十堰市科学技术研究与开发项目(14Y59)
关键词 儿茶酚抑素 心肌梗死 心肌纤维化 Catechol endostatin Myocardial infarction Myocardial fibrosis
  • 相关文献

参考文献17

  • 1Jansson AM, Rasjo H,Omland T, et al. Prognostic value of cir- culating chromogranin A levels in acute coronary syndromes [ J ]. Eur Heart J ,2009,30:25-32.
  • 2Omland T,Dickstein K, Syversen U. Association between plas- ma chromogranin A concentration and long-term mortality af- ter MI [ J ]. Am J Med,2003 ,114 :25-30 M.
  • 3ahata SK, Mahata M, Fung MM, et al. Catestatin : a multi- functional peptide from chromogranin A [J]. Regul Pept, 2010,162:33-43.
  • 4Kennedy BP, Mahata SK, O'Connor DT. et al. Mechanism of cardiovascular actions of the chromogranin A fragment catesta- tin in vivo[ J]. Peptides, 1998,19 : 1241-1248.
  • 5O'Connor DT, Kailasam MT, Kennedy BP, et al. Early decline in the catecholamine release inhibitory peptide catestatin in hu- mans at genetic risk of hypertension [ J ]. J Hypertens, 2002, 20 : 1335-1345.
  • 6Mahapatra NR, O'Connor DT, Vaingankar SM, et al. Hyper- tension from targeted ablation of chromogranin A can be res- cued by the human orthology[J]. J Clin Invest, 2005,115 : 1942-1952.
  • 7Angelone T, Quintieri AM, Brar BK, et al. The anfihypertens- ire chrornogranin A peptide catestatin acts as a novel endo- cfine/paracrine modulator of cardiac inotropism and lusitro- pism [ J ]. Endocrinology, 2008,149:4780 -4793.
  • 8Massare J, BmTy JM, Luo X, et al. Diminished cardiac fibrosis in heart failure is associated with altered ventricular arrhythmia phenotype [ J ]. J Cardiovasc Electrophysiol, 2010,21 : 1031- 1037.
  • 9Wang Y, Xuan YL, Hu HS, et al. Risk of ventricular arrhyth- mias after myocardial infarction with diabetes associated with sympathetic neural remodeling in rabbits [ J ]. Cardiology, 2012,121(1) :1-9.
  • 10Helle KB. The chromogranin A-derived peptides vasostatin-I and catestatin as regulatory peptides for cardiovascular func- tions [ J ]. Cardiovasc Res, 2010,85 : 9-16.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部